2025 Lupus Research Alliance Gala Raises Millions to Bring New Treatments and a Cure
GRAMMY® Award-winning Artist Rob Thomas Headlines Evening Honoring Partners iHeart Media and Genentech The Lupus Research Alliance, the largest private...
Gazyva
Obinutuzumab Showed Significantly Positive Results in Published Phase III Lupus Nephritis Study
Exciting breaking news: A paper published in the highly prestigious journal New England Journal of Medicine and presented at...
Gazyva® Shows Positive Results in Phase 3 Lupus Nephritis Trial
The Lupus Research Alliance (LRA) and clinical research affiliate Lupus Therapeutics (LT) are excited to share positive news of...
Encouraging Results with Obinutuzumab for Lupus Nephritis
February 13, 2022
The LRA is pleased to share a recently published paper reporting that the drug, obinutuzumab, showed positive...
LRA Shares Excitement For What’s Ahead in Lupus Nephritis
January 16, 2020
Up to half of people with lupus will have lupus nephritis – damage to the kidneys that...
Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis
NEW YORK, Nov. 10, 2019 /PRNewswire/ -- The Lupus Research Alliance (LRA) is pleased to acknowledge positive results presented by...
FDA Expedites Existing Drug Gazyva for Lupus Nephritis
September 18, 2019
The LRA is pleased to share that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy...
Lupus Research Alliance Pleased to Share Positive News about Potential Drug for Lupus Nephritis
NEW YORK, NY. June 11, 2019. The Lupus Research Alliance is pleased to share positive topline results from a...